What is Addition Technology?
Based in Illinois, Addition Technology specializes in the production of high-quality ophthalmic products, including Intacs, which are FDA-approved intracorneal segments. Operating within ISO13485 certified facilities, the company adheres to stringent medical device regulations. Addition Technology's commitment to innovation is further demonstrated through its collaborations with ophthalmologists and research institutions, aiming to advance global vision care solutions for both human and veterinary applications. Their product portfolio focuses on providing reliable devices for vision stabilization and improvement.
How much funding has Addition Technology raised?
Addition Technology has raised a total of $67K across 1 funding round:
Debt
$67K
Debt (2021): $67K with participation from PPP
Key Investors in Addition Technology
PPP
Public-Private Partnership
What's next for Addition Technology?
With the infusion of substantial expansion capital, Addition Technology is poised for accelerated growth and market penetration. The company's focus on FDA-approved devices and adherence to rigorous quality standards positions it favorably within the competitive ophthalmic device sector. Future strategic initiatives are likely to involve scaling production, expanding distribution channels, and potentially developing next-generation ophthalmic solutions. This investment will be critical in supporting their ongoing research and development efforts and solidifying their market presence in both human and veterinary ophthalmology.
See full Addition Technology company page
